ArticleNeurosurgical review2025
Iron status and risk of aneurysmal subarachnoid hemorrhage: evidence from a two-sample Mendelian randomization.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Observational studies have reported associations between iron status and aneurysmal subarachnoid hemorrhage (aSAH) and its complications. However, the causal relationship between these factors remains unclear. This Mendelian Randomization (MR) study adhered to the Strengthening Reporting of Observational Studies in Epidemiology using Mendelian Randomization (STROBE-MR) guidelines. Data for iron status and aneurysmal subarachnoid hemorrhage (aSAH) were sourced from genome-wide association studies (GWAS) available in public databases. The primary MR analysis was conducted using the inverse variance weighted (IVW) random-effects models. To ensure the robustness of the causal inferences, we performed sensitivity analyses. The effects from various analytical models and heterogeneity were visualized using scatter plots and funnel plots, respectively. Our analysis supported a causal association under MR assumptions between iron status and aSAH. Specifically, transferrin saturation (TSAT) was associated with a decreased risk of aSAH (OR = 0.726, 95% CI: 0.568–0.927, P = 0.010), while total iron-binding capacity (TIBC) was associated with an increased risk (OR = 1.989, 95% CI: 1.301–3.042, P = 0.002). No causal association was identified between iron or ferritin levels and aSAH. Additionally, reverse MR analysis indicated no causal relationship between aSAH and iron status. Under MR assumptions, our study supports a causal association between iron-status markers (TSAT, TIBC) and aSAH. Clinical implications require prospective validation.
Indexed as
Identifiers
41188639What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.